1. Immunogenicity and safety of H1N1 vaccination in anorexia nervosa-Results from a pilot study.
- Author
-
Zastrow, Arne, Schnitzler, Paul, Eckerle, Isabella, Herzog, Wolfgang, and Friederich, Hans‐Christoph
- Subjects
- *
BLOOD testing , *ANALYSIS of variance , *ANOREXIA nervosa , *COMPARATIVE studies , *ENZYME-linked immunosorbent assay , *INFLUENZA vaccines , *RESEARCH , *RESEARCH funding , *BODY mass index , *INFLUENZA A virus, H1N1 subtype , *DATA analysis software - Abstract
Objective: In anorexia nervosa (AN) patients immunologic alterations are known, although their clinical significance remains a matter of debate. Currently, no recommendation can be given on the safety and immunogenicity of indicated vaccinations in this malnourished population. Method: In this exploratory study, 10 AN patients' (eight female, two male, mean age 31.1 years, SD 16.3 years; mean BMI 14.8 kg/m2, SD 1.6 kg/m2) antibody levels against H1N1 influenza were measured before vaccination, and were followed-up for two and three weeks after vaccination. They were compared with the immunological response in normal weight population, as reported in the literature. Clinical and socio-demographical data were collected. Results: In the AN group, H1N1 vaccination showed to be sufficiently immunogenic and safe, comparable to published data of normal weight population. Discussion: The findings provide preliminary evidence that vaccination seems recommendable even in extremely underweight AN patients. Further studies are needed to corroborate the present findings. © 2011 by Wiley Periodicals, Inc. (Int J Eat Disord 2012) [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF